For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220427:nRSa5823Ja&default-theme=true
RNS Number : 5823J Spire Healthcare Group PLC 27 April 2022
27 April 2022
Spire Healthcare Group plc
Grant of Sharesave Plan Options
Notification of Transactions by Persons Discharging Managerial
Responsibilities ("PDMRs")
Spire Healthcare Group plc (the "Company") announces that following valid
elections by the PDMRs disclosed in the table below to participate in the
Company's all-employee Sharesave Plan, options over the Company's ordinary
shares of 1p each ("Ordinary Shares") were granted on 26 April 2022 as
follows:
Directors Number of Ordinary Shares under Option Exercise Price per Ordinary Share
Justin Ash 1,818 £1.98
Jitesh Sodha 1,818 £1.98
Other PDMRs Number of Ordinary Shares under Option Exercise Price per Ordinary Share
John Forrest 1,818 £1.98
Harbant Samra 1,818 £1.98
Subject to the rules of the Spire Healthcare Group plc 2016 Sharesave Plan,
the options may be exercised at the end of the three year saving contract at
the exercise price set out above. The expected maturity date of these
options is 1 June 2025 and they will remain exercisable until 30 November
2025.
Name of contact and telephone number for queries:
Philip Davies
07803
508348
Company Secretary
The following disclosure is made in accordance with Article 19 of the EU
Market Abuse Regulation 596/2014.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name John Forrest
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Harbant Samra
2 Reason for the notification
a) Position/status Interim Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDSISDDGDR